Cargando…

Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8(+) Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3)

Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step of tryptophan catabolism in a specific pathway, resulting in a series of extracellular messengers collectively known as kynurenines. IDO has been recognized as an authentic regulator of immunity not only in mammalian preg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pallotta, Maria T., Orabona, Ciriana, Volpi, Claudia, Grohmann, Ursula, Puccetti, Paolo, Fallarino, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2010
Materias:	Original Research – Special Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195250/ https://www.ncbi.nlm.nih.gov/pubmed/22084591

Ejemplares similares

The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes
por: Mondanelli, Giada, et al.
Publicado: (2017)

Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry
por: Coletti, Alice, et al.
Publicado: (2017)

Distinct roles of immunoreceptor tyrosine‐based motifs in immunosuppressive indoleamine 2,3‐dioxygenase 1
por: Albini, Elisa, et al.
Publicado: (2016)

Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme
por: Pallotta, Maria Teresa, et al.
Publicado: (2021)

Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1
por: Romani, Rita, et al.
Publicado: (2015)

Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production
por: Bellucci, Michele, et al.
Publicado: (2021)

Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice
por: Proietti, Elisa, et al.
Publicado: (2023)

Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function
por: Suvieri, Chiara, et al.
Publicado: (2023)

Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
por: Zhao, Fei, et al.
Publicado: (2014)

IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1
por: Panfili, Eleonora, et al.
Publicado: (2019)

Hypoxia enhances indoleamine 2,3-dioxygenase production in dendritic cells
por: Song, Xiang, et al.
Publicado: (2018)

Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes
por: Pallotta, Maria Teresa, et al.
Publicado: (2014)

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020)

Targeting the indoleamine 2,3-dioxygenase pathway in cancer
por: Moon, Yong Wha, et al.
Publicado: (2015)

Fludarabine Downregulates Indoleamine 2,3-Dioxygenase in Tumors via a Proteasome-Mediated Degradation Mechanism
por: Hanafi, Laïla-Aïcha, et al.
Publicado: (2014)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases
por: Zhou, Qihui, et al.
Publicado: (2021)

A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice
por: Grohmann, Ursula, et al.
Publicado: (2003)

CTLA-4–Ig Activates Forkhead Transcription Factors and Protects Dendritic Cells from Oxidative Stress in Nonobese Diabetic Mice
por: Fallarino, Francesca, et al.
Publicado: (2004)

Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication
por: Gargaro, Marco, et al.
Publicado: (2022)

The Mechanism of Substrate Inhibition in Human Indoleamine 2,3-Dioxygenase
por: Efimov, Igor, et al.
Publicado: (2012)

Indoleamine-2,3-dioxygenase activity induces neutrophil apoptosis
por: Van der Sluijs, K, et al.
Publicado: (2011)

Indoleamine-2,3-dioxygenase activity in experimental human endotoxemia
por: Padberg, Jan-Sören, et al.
Publicado: (2012)

The role of placental indoleamine 2,3-dioxygenase in human pregnancy
por: Kudo, Yoshiki
Publicado: (2013)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
por: Mellor, Andrew L., et al.
Publicado: (2017)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
por: Acovic, Aleksandar, et al.
Publicado: (2018)

Role of indoleamine 2,3-dioxygenase in testicular immune-privilege
por: Gualdoni, Gisela S., et al.
Publicado: (2019)

Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase
por: Yoshioka, Saeko, et al.
Publicado: (2022)

Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer
por: Chen, I-Chien, et al.
Publicado: (2016)

Indoleamine 2,3-Dioxygenase in Human Hematopoietic Stem Cell Transplantation
por: Jürgens, Birgit, et al.
Publicado: (2010)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
por: Gao, Yan-Fang, et al.
Publicado: (2009)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis
por: Shibata, Yuhei, et al.
Publicado: (2016)

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
por: Zulfiqar, Bilal, et al.
Publicado: (2017)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
por: Hornyák, Lilla, et al.
Publicado: (2018)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
por: Zhang, Tao, et al.
Publicado: (2017)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
por: Hirata, Nao, et al.
Publicado: (2018)

Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy
por: Deng, Ning, et al.
Publicado: (2021)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
por: Jensen, Camilla Grønkjær, et al.
Publicado: (2021)

Indoleamine-2,3-Dioxygenase as a Perioperative Marker of the Immune System
por: Bello, Corina, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
por: Farooq, Asim, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fuf2utac31tj65cfh1cs5lqhsh